Login / Signup

Remimazolam-based total intravenous anesthesia in a patient with a confirmed diagnosis of malignant hyperthermia: a case report.

Hiroshi KondoKeiko MukaidaKurumi SasaiYukiko NaoKen HashimotoHirotsugu MiyoshiRieko KanzakiYasuo M Tsutsumi
Published in: JA clinical reports (2024)
Remimazolam-based TIVA is safe in patients confirming the diagnosis of MH.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • peritoneal dialysis
  • prognostic factors
  • case report
  • patient reported outcomes
  • low dose